Optimized D-α-tocopherol polyethylene glycol succinate/phospholipid self-assembled mixed micelles: A promising lipid-based nanoplatform for augmenting the antifungal activity of fluconazole

Badr-Eldin, Shaimaa M.; Aldawsari, Hibah M.; Fahmy, Usama A.; Ahmed, Osama A. A.; Alhakamy, Nabil A.; Elfaky, Mahmoud A.; Sirwi, Alaa; Hawsawi, Salman A.; Alzahrani, Ali H.; Yaseen, Abdulrahman Y.; Qassim, Mohannad; Kotta, Sabna

doi:10.2478/acph-2022-0028

Abstract

Fluconazole (FLZ) is the most widely used antifungal agent for treating cutaneous candidiasis. Although oral FLZ has been proved to be effective, the incidence of side effects necessitates the development of an effective formulation that could surpass the pitfalls associated with systemic availability. Accordingly, this research aimed at developing a self-assembled mixed micelles topical delivery system to enhance the topical delivery of the drug. Self-assembled mixed micelles were developed using D-α-tocopheryl polyethylene glycol 1000 succinate and phospholipids and optimized using Box-Behnken design. The optimized formulation with minimized size was then tested in vivo for the antifungal activity against C. albicans in immunocompromised mice. Treatment with the optimized formulation led to decreased peripheral erythema as well as lesions due to fungal infection in comparison to raw FLZ loaded gel. Therefore, the developed formulation was found to be a promising vehicle for the treatment of cutaneous candidiasis.

References

1. B. Healy and R. Barnes, Topical and oral treatments for fungal skin infections, Prescriber 17(7) (2006) 30–43; https://doi.org/10.1002/psb.360
Search in Google Scholar Back to article
2. R. Coppola, S. Zanframundo, M. V. Rinati, M. Carbotti, A. Graziano, G. Galati, L. De Florio and V. Panasiti, Rhodotorula mucilaginosa skin infection in a patient treated with sorafenib, J. Eur. Acad. Dermatol. Venereol. 29(5) (2015) 1028–1029; https://doi.org/10.1111/jdv.12455
Search in Google Scholar Back to article
3. E. Palese, M. Nudo, G. Zino, V. Devirgiliis, M. Carbotti, E. Cinelli, D. M. Rodio, A. Bressan, C. Prezioso, C. Ambrosi, D. Scribano, V. Pietropaolo, D. Fioriti and V. Panasiti, Cutaneous candidiasis caused by Candida albicans in a young non-immunosuppressed patient: an unusual presentation, Int. J. Immunopathol. Pharmacol. 32 (2018) 1–4; https://doi.org/10.1177/2058738418781368
Search in Google Scholar Back to article
4. S. Bhattacharya, S. Sae-Tia and B. C. Fries, Candidiasis and mechanisms of antifungal resistance, Antibiotics 9(6) (2020) Article ID 312 (19 pages); https://doi.org/10.3390/antibiotics9060312
Search in Google Scholar Back to article
5. M. V. Martin, The use of fluconazole and itraconazole in the treatment of Candida albicans infections: a review, J. Antimicrob. Chemother. 44(4) (1999) 429–437; https://doi.org/10.1093/jac/44.4.429
Search in Google Scholar Back to article
6. P. Suchil, F. Montero Gei, M. Robles, A. Perera-Ramirez, O. Welsh and O. Male, Once-weekly oral doses of fluconazole 150 mg in the treatment of tinea corporis/cruris and cutaneous candidiasis, Clin. Exp. Dermatol. 17(6) (1992) 397–401; https://doi.org/10.1111/j.1365-2230.1992.tb00246.x
Search in Google Scholar Back to article
7. B. Darwesh, H. M. Aldawsari and S. M. Badr-Eldin, Optimized chitosan/anion polyelectrolyte complex based inserts for vaginal delivery of fluconazole: In vitro/in vivo evaluation, Pharmaceutics 10(4) (2018) Article ID 227 (16 pages); https://doi.org/10.3390/pharmaceutics10040227
Search in Google Scholar Back to article
8. H. M. Ellaithy and K. M. F. El-Shaboury, The development of Cutina lipogels and gel microemulsion for topical administration of fluconazole, AAPS PharmSciTech 3 (2002) 77–85; https://doi.org/10.1208/pt030435
Search in Google Scholar Back to article
9. M. Gupta, S. Tiwari and S. P. Vyas, Influence of various lipid core on characteristics of SLNs designed for topical delivery of fluconazole against cutaneous candidiasis, Pharm. Dev. Technol. 18(3) (2013) 550–559; https://doi.org/10.3109/10837450.2011.598161
Search in Google Scholar Back to article
10. V. Prajapati, A. Jain, R. Jain, S. Sahu and D. V. Kohli, Treatment of cutaneous candidiasis through fluconazole encapsulated cubosomes, Drug Deliv. Transl. Res. 4 (2014) 400–408; https://doi.org/10.1007/s13346-014-0202-2
Search in Google Scholar Back to article
11. T. O. McDonald, M. Siccardi, D. Moss, N. Liptrott, M. Giardiello, S. Rannard and A. Owen, The Application of Nanotechnology to Drug Delivery in Medicine, in Nanoengineering Global Approaches to Health and Safety Issues, Elsevier 2015, pp. 173–223.
Search in Google Scholar Back to article
12. W. Weng, Q. Wang, C. Wei, M. Adu-Frimpong, E. Toreniyazov, H. Ji, J. Yu and X. Xu, Mixed micelles for enhanced oral bioavailability and hypolipidemic effect of liquiritin: preparation, in vitro and in vivo evaluation, Drug Dev. Ind. Pharm. 47(2) (2021) 308–318; https://doi.org/10.1080/03639045.2021.1879839
Search in Google Scholar Back to article
13. O. A. A. Ahmed, K. M. El-Say, B. M. Aljaeid, S. M. Badr-Eldin and T. A. Ahmed, Optimized vinpocetine-loaded vitamin E D-α-tocopherol polyethylene glycol 1000 succinate-alpha lipoic acid micelles as a potential transdermal drug delivery system: in vitro and ex vivo studies, Int. J. Nanomedicine 2018(14) 33–43; https://doi.org/10.2147/IJN.S187470
Search in Google Scholar Back to article
14. O. A. A. Ahmed and S. M. Badr-Eldin, In situ misemgel as a multifunctional dual-absorption platform for nasal delivery of raloxifene hydrochloride: formulation, characterization, and in vivo performance, Int. J. Nanomedicine 2018(13) 6325–6335; https://doi.org/10.2147/IJN.S181587
Search in Google Scholar Back to article
15. J. Sobczyński and B. Chudzik-Rząd, Mixed Micelles as Drug Delivery Nanocarriers, in Design and Develop ment of New Nanocarriers, Elsevier 2018, pp. 331–364.
Search in Google Scholar Back to article
16. L. C. Chen, Y. C. Chen, C. Y. Su, W. P. Wong, M. T. Sheu and H. O. Ho, Development and Characterization of lecithin-based self-assembling mixed polymeric micellar (saMPMs) drug delivery systems for curcumin, Sci. Rep. 6 (2016) Article ID 37122 (11 pages); https://doi.org/10.1038/srep37122
Search in Google Scholar Back to article
17. L. Mu and S. S. Feng, PLGA/TPGS nanoparticles for controlled release of paclitaxel: effects of the emulsifier and drug loading ratio, Pharm. Res. 20 (2003) 1864–1872; https://doi.org/10.1023/B:PHAM.0000003387.15428.42
Search in Google Scholar Back to article
18. J. Song, H. Huang, Z. Xia, Y. Wei, N. Yao, L. Zhang, H. Yan, X. Jia and Z. Zhang, TPGS/phospholipids mixed micelles for delivery of icariside II to multidrug-resistant breast cancer, Integr. Cancer Ther. 15(3) (2016) 390–399; https://doi.org/10.1177/1534735415596571
Search in Google Scholar Back to article
19. M. L. Manca, C. Cencetti, P. Matricardi, I. Castangia, M. Zaru, O. D. Sales, A. Nacher, D. Valenti, A. M. Maccioni, A. M. Fadda and M. Manconi, Glycerosomes: Use of hydrogenated soy phosphatidylcholine mixture and its effect on vesicle features and diclofenac skin penetration, Int. J. Pharm. 511(1) (2016) 198–204; https://doi.org/10.1016/j.ijpharm.2016.07.009
Search in Google Scholar Back to article
20. M. J. Naguib, S. Salah, S. A. Abdel Halim and S. M. Badr-Eldin, Investigating the potential of utilizing glycerosomes as a novel vesicular platform for enhancing intranasal delivery of lacidipine, Int. J. Pharm. 582 (2020) Article ID 119302 (14 pages); https://doi.org/10.1016/j.ijpharm.2020.119302
Search in Google Scholar Back to article
21. R. Shen, J. Kim, M. Yao and T. A. Elbayoumi, Development and evaluation of vitamin E D-α-tocopheryl polyethylene glycol 1000 succinate-mixed polymeric phospholipid micelles of berberine as an anticancer nanopharmaceutical, Int. J. Nanomedicine 2016(11) 1687–1700; https://doi.org/10.2147/IJN.S103332
Search in Google Scholar Back to article
22. N. A. Alhakamy, O. A. Ahmed, U. A. Fahmy, H. Z. Asfour, A. F. Alghaith, W. A. Mahdi, S. Alshehri and S. Md, Development, Optimization and evaluation of 2-methoxy-estradiol loaded nanocarrier for prostate cancer, Front. Pharmacol. 12 (2021) Article ID 682337 (14 pages); https://doi.org/10.3389/FPHAR.2021.682337
Search in Google Scholar Back to article
23. W. H. Abd-Elsalam, S. A. El-Zahaby and A. M. Al-Mahallawi, Formulation and in vivo assessment of terconazole-loaded polymeric mixed micelles enriched with Cremophor EL as dual functioning mediator for augmenting physical stability and skin delivery, Drug Deliv. 25(1) (2018) 484–492; https://doi.org/10.1080/10717544.2018.1436098
Search in Google Scholar Back to article
24. P. Sadasivudu, N. Shastri and M. Sadanandam, Development and validation of RP-HPLC and UV methods of analysis for fluconazole in pharmaceutical solid dosage forms, Int. J. ChemTech Res. 1(4) (2009) 1131–1136.
Search in Google Scholar Back to article
25. S. El-Housiny, M. A. S. Eldeen, Y. A. El-Attar, H. A. Salem, D. Attia, E. R. Bendas and M. A. El-Nabarawi, Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: formulation and clinical study, Drug Deliv. 25(1) (2018) 78–90; https://doi.org/10.1080/10717544.2017.1413444
Search in Google Scholar Back to article
26. I. Angulo, M. B. Jiménez-Díaz, J. F. García-Bustos, D. Gargallo, F. Gómez de las Heras, M. A. Muñoz-Fernández and M. Fresno, Candida albicans infection enhances immunosuppression induced by cyclophosphamide by selective priming of suppressive myeloid progenitors for NO production, Cell. Immunol. 218(1–2) (2002) 46–58; https://doi.org/10.1016/S0008-8749(02)00521-X
Search in Google Scholar Back to article
27. K. Maebashi, T. Itoyama, K. Uchida, N. Suegara and H. Yamaguchi, A novel model of cutaneous candidiasis produced in prednisolone-treated guinea-pigs, J. Med. Vet. Mycol. 32(5) (1994) 349–359; https://doi.org/10.1080/02681219480000471
Search in Google Scholar Back to article
28. S. M. Badr-Eldin, N. A. Alhakamy, U. A. Fahmy, O. A. A. Ahmed, H. Z. Asfour, A. A. Althagafi, H. M. Aldawsari, W. Y. Rizg, W. A. Mahdi, A. F. Alghaith, S. Alshehri, F. Caraci and G. Caruso, Cytotoxic and pro-apoptotic effects of a sub-toxic concentration of fluvastatin on OVCAR3 ovarian cancer cells after its optimized formulation to melittin nano-conjugates, Front. Pharmacol. 11 (2021) Article ID 642171 (12 pages); https://doi.org/10.3389/fphar.2020.642171
Search in Google Scholar Back to article
29. U. A. Fahmy, S. M. Badr-Eldin, O. A. A. Ahmed, H. M. Aldawsari, S. Tima, H. Z. Asfour, M. W. Al-Rabia, A. A. Negm, M. H. Sultan, O. A. A. Madkhali and N. A. Alhakamy, Intranasal niosomal in situ gel as a promising approach for enhancing flibanserin bioavailability and brain delivery: In vitro optimization and ex vivo/in vivo evaluation, Pharmaceutics 12(6) (2020) Article ID 485 (23 pages); https://doi.org/10.3390/pharmaceutics12060485
Search in Google Scholar Back to article
30. Z. M. Adib, S. Ghanbarzadeh, M. Kouhsoltani, A. Y. Khosroshahi and H. Hamishehkar, The effect of particle size on the deposition of solid lipid nanoparticles in different skin layers: A histological study, Adv. Pharm. Bull. 6(1) (2016) 31–36; https://doi.org/10.15171/apb.2016.006
Search in Google Scholar Back to article
31. R. Sharma, S. Kamboj, G. Singh and V. Rana, Development of aprepitant loaded orally disintegrating films for enhanced pharmacokinetic performance, Eur. J. Pharm. Sci. 84 (2016) 55–69; https://doi.org/10.1016/j.ejps.2016.01.006
Search in Google Scholar Back to article
32. J. Singh, P. Mittal, G. Vasant Bonde, G. Ajmal and B. Mishra, Design, optimization, characterization and in-vivo evaluation of Quercetin enveloped Soluplus®/P407 micelles in diabetes treatment, Artif. Cells Nanomedicine Biotechnol. 46(sup3) (2018) S546–S555; https://doi.org/10.1080/21691401.2018.1501379
Search in Google Scholar Back to article
33. A. E. S. F. Abou El Ela and M. M. El Khatib, Formulation and evaluation of new long acting metoprolol tartrate ophthalmic gels, Saudi Pharm. J. 22(6) (2014) 555–563; https://doi.org/10.1016/j.jsps.2014.03.003
Search in Google Scholar Back to article
34. A. A. Alhowyan, M. A. Altamimi, M. A. Kalam, A. A. Khan, M. Badran, Z. Binkhathlan, M. Alkholief and A. Alshamsan, Antifungal efficacy of Itraconazole loaded PLGA-nanoparticles stabilized by vitamin-E TPGS: In vitro and ex vivo studies, J. Microbiol. Methods 161 (2019) 87–95; https://doi.org/10.1016/j.mimet.2019.01.020
Search in Google Scholar Back to article
35. L. Qiu, B. Hu, H. Chen, S. Li, Y. Hu, Y. Zheng and X. Wu, Antifungal efficacy of itraconazole-loaded TPGS-b-(PCL-ran-PGA) nanoparticles, Int. J. Nanomedicine 2015(10) 1415–1423; https://doi.org/10.2147/IJN.S71616
Search in Google Scholar Back to article

Optimized D-α-tocopherol polyethylene glycol succinate/phospholipid self-assembled mixed micelles: A promising lipid-based nanoplatform for augmenting the antifungal activity of fluconazole

Abstract

Paradigm

My account